NKIO

Zelluna

This company develops T cell receptor guided natural killer cell therapies to treat patients with solid cancers.

ARTV

This clinical-stage biotechnology company develops natural killer cell therapies for patients with autoimmune diseases and cancers.

LYEL

This company develops engineered cell therapies to treat patients with solid tumours and blood cancers.

Nkarta

This biopharmaceutical company develops engineered natural killer cell therapies to treat patients with cancer and autoimmune diseases.

Catamaran Bio

This biotechnology company develops off-the-shelf allogeneic cell therapies for patients with solid tumours and other cancers using natural killer cells.

NeoPhore

This company develops small-molecule immuno-oncology medicines that inhibit DNA mismatch repair to stimulate immune responses against cancer for patients with solid tumours.

Artiva Biotherapeutics

The company develops allogeneic natural killer cell therapies for patients with autoimmune diseases and cancer.

Nectin Therapeutics

This company develops novel immunotherapeutic antibodies and antibody-drug conjugates for patients with solid and haematological cancers.